Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 26.78 billion as of May 23, 2025. Its market cap has increased by 17.17% in one year.

Market Cap

26.78B

Enterprise Value

27.59B

Revenue

4.62B

Ranking

n/a

PE Ratio

1.16

Stock Price

12.30

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 26.78B, an increase of 1,167.95%. That is a compound annual growth rate of 31.02%.

Market Cap History

Date	Market Cap	% Change
May 22, 2025	25.54B	21.05%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	200.29B
Hansoh Pharmaceutical Group Company	152.81B
JD Health International	132.72B
WuXi Biologics	97.74B
Innovent Biologics	92.79B
Akeso	77.19B
Sino Biopharmaceutical	75.33B
Sichuan Kelun-Biotech Biopharmaceutical	74.98B

Market Cap Rankings